Reparatory system 18 lectures Heyam Awad

Similar documents
Reparatory system lectures Heyam Awad

Lung tumors & pleural lesions

Lung diseases. Fatima Obeidat, MD Assistant Professor of Pathology/Neuropathology University of Jordan

Bronchogenic Carcinoma

Pathology of Tumors of Lung Pathology of Tumors of Lung o Classify lung tumors.

Respiratory Tract Cytology

Cancer in the United States, 2004

Lung Cancer Risks. Cancer in the United States, Cancer Death Rates, US The Scheme: From Nicotine Addiction to Lung Cancer

Respiratory Interactive Session. Elaine Borg

Lung diseases of Vascular Origin. By: Shefaa Qa qqa

3/30/2009 Lung Cancer Deaths 2008 Lung Cancer Deaths Lung Cancer Deaths--Males Males 5

Lung Cancer Incidence 2008 Lung Cancer Deaths-Males 2008 Incidence Total U.S.(all types): 1,437,180 Lung Cancer Deaths-Females Lung cancer 215,000(15%

Lung Cancer: Diagnosis, Staging and Treatment

A 64 y.o. man presents to the hospital with persistent cough and hemoptysis. Fernando Mut Montevideo - Uruguay

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD. November 18, 2017

Non Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק

Lung Cancer Very common Very lethal Median age of diagnosis i approximately 70 years, but affects all ages In the United States, the highest incidence

Difficult Diagnoses and Controversial Entities in Neoplastic Lung

Lung Cancer. Definition of lung cancer Malignancy arising from lung tissue

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

Respiratory Pathology. Kristine Krafts, M.D.

Gastrointestinal pathology 2018 lecture 4. Dr Heyam Awad FRCPath

LUNG CANCER. Agnieszka Słowik, MD. Department of Oncology, University Hospital in Cracow Jagiellonian University

Cytological Sub-classification of Lung Cancer: Morphologic and Molecular Characteristics. Mercè Jordà, University of Miami

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma.

Lung Cancer-a primer. Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology

B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life.

EBUS-TBNA Diagnosis and Staging of Lung Cancer

Chief Complain. For chemotherapy

LUNG CANCER. pathology & molecular biology. Izidor Kern University Clinic Golnik, Slovenia

Lung Cytology: Lessons Learned from Errors in Practice

Gastrointestinal pathology 2018 lecture 2. Dr Heyam Awad FRCPath

Lung Tumors. Objectives: Editing File

Slide 120, Lobar Pneumonia. Slide 120, Lobar Pneumonia. Slide 172, Interstitial Pneumonia. Slide 172, Interstitial Pneumonia. 53 Year-Old Smoker

Molecular Pathobiology of Lung Cancer. William K. Funkhouser, MD PhD Department of Pathology and Lab Medicine University of North Carolina

Neoplasia. (4&5 of 6)

PDF created with pdffactory Pro trial version

ONCOLOGY. Csaba Bödör. Department of Pathology and Experimental Cancer Research november 19., ÁOK, III.

CNS pathology Third year medical students. Dr Heyam Awad 2018 Lecture 12: CNS tumours 2/3

Outline. The Lung Cancer Patient in 2011 Not the Marlboro Man. Lung Cancer

NEOPLASMS OF THE THYROID PATHOLOGY OF PARATHYROID GLANDS. BY: Shifaa Qa qa

Lung Cancer Case Study

Human Lung Cancer Pathology and Cellular Biology Mouse Lung Tumor Workshop

Histopathology of NSCLC, IHC markers and ptnm classification

LUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS

Histopathological and CT Imaging Correlation of Various Primary Lung Carcinoma

Problem 1: Differential of Neuroendocrine Carcinoma 3/23/2017. Disclosure of Relevant Financial Relationships

INDEX. surgpath.theclinics.com. Note: Page numbers of article titles are in boldface type. diffuse pleural fibrosis, pleural plaques,

8/22/2016. Major risk factors for the development of lung cancer are: Outline

Renal tumors of adults

B. Cystic Teratoma: Refer to virtual microscope slide p_223 ovary, teratoma and compare to normal virtual microscope slide 086 ovary.

SESSION 1: GENERAL (BASIC) PATHOLOGY CONCEPTS Thursday, October 16, :30am - 11:30am FACULTY COPY

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Cancer in the United States, 2007

Diseases of oral cavity

Smoke Like a Man, Survive Like a Woman

Lecture Goals. Lung (Bronchogenic) Cancer. Causes of Lung Cancer. Elizabeth Weihe, MD Assistant Professor of Radiology Director of UCSD RECIST clinic

Neoplasia 2018 lecture 11. Dr H Awad FRCPath

New lung lesion in a 55 year-old male treated with chemoradiation for non-small cell lung carcinoma

A clinical syndrome, composed mainly of:

Lung Neoplasia II Resection specimens Pathobasic. Lukas Bubendorf Pathology

Renal Parenchymal Neoplasms

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010

Cancer in the United States, 2009

Cancer in the United States, Lung Cancer Risks. Cancer Death Rates, US The Scheme: From Nicotine Addiction to Lung Cancer

Personalized Genetics

Definition. Epidemiology. Lung Cancer is a disease which cancer (malignant tumors) cells grow in the lungs. LUNG CANCER Debra Mercer BSN, RN, RRT

Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON

Cancer in the United States, Jemal, A. et al. CA Cancer J Clin 2009;59:

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

Lung Cancer - Suspected

Personalized Medicine: Lung Biopsy and Tumor

Carcinoma of Unknown Primary site (CUP) in HEAD & NECK SURGERY

SESSION IV: MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS PULMONARY PATHOLOGY I. December 5, 2012

Lung /1/16. Please submit all questions concerning webinar content through the Q&A panel. Reminder:

TUMOR,NEOPLASM. Pathology Department, Zhejiang University School of Medicine,

THYMIC CARCINOMAS AN UPDATE

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.

INTRODUCTION TO PATHOLOGICAL TECHNIQUES. 1. Types of routine biopsy procedures 2. Special exams (IHC, FISH)

Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED

Charles Mulligan, MD, FACS, FCCP 26 March 2015

Tumor Board Discussions: Case 1

NEOPLASIA. 3. Which of the following tumour is benign a. Chondrosarcoma b. Osteochondroma c. Chondroblastoma d. Ewing s tumour e.

Neuroendocrine Lung Tumors Myers

SMALL CELL LUNG CANCER Updated Feb 2017 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary)

Note: The cause of testicular neoplasms remains unknown

Case of the Day Chest

Human Papillomavirus Testing in Head and Neck Carcinomas

The Scheme: From Nicotine Addiction to Lung Cancer

GOALS AND OBJECTIVES FOR THORACIC PATHOLOGY ROTATION

Pulmonary Neoplasm. Howard J. Sachs, MD

Rapidly Progressive Skin Metastasis in EGFR Wild and ALK Fusion Negative Adenocarcinoma Lung: An Unusual Presentation

Lung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09

Presentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98

Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine

Transcription:

Reparatory system 18 lectures 8-10 Heyam Awad

These lectures cover the following topics 1. Diffuse hemorrhagic syndromes 2. Lung tumors important: theses slides are your study source for these lectures. there is no handout for these. the slides are detailed and are enough for the exam.

Diffuse alveolar hemorrhagic syndromes These are a group of primary immune mediated diseases that manifest as hemoptysis, anemia and diffuse pulmonary infiltrates. These diseases include the following entities: 1. Goodpasture syndrome 2. idiopathic pulmonary hemosiderosis

1. Goodpasture Syndrome Goodpasture syndrome -this is an uncommon, rapidly progressive, glomerulonephritis and hemorrhagic interstitial pneumonitis. - Both the renal and the pulmonary lesions are caused by antibodies targeted against the non-collagenous domain of the α3 chain of collagen IV which can be detected in the serum of more than 90% of patients - So this is an example of type 2 hypersensitivity reaction.

Note that in type 2 hypersensitivity the antibodies are deposited in tissues and they cause damage by several mechanisms including opsonization and phagocytosis, inflammation through complement fixation or direct cellular dysfunction. In Goodpasture syndrome the antibodies activate complement by the classical pathway. This triggers an inflammatory reaction.

morphology The lungs are heavy with red brown consolidation due to diffuse hemorrhage within the alveoli. Microscopy shows necrosis of alveolar walls and associated alveolar hemorrhage.

- The characteristic linear pattern of immunoglobulin deposition (usually IgG, that is the hallmark diagnostic finding in renal biopsy specimens may be seen along the alveolar septa by immunoflurescence studies. - Plasmapheresis which removes the offending agent and immunosuppressive therapy that inhibits antibody formation have markedly improved the prognosis - With severe renal disease, renal transplantation is eventually required

Linear IgG

Idiopathic Pulmonary Hemosiderosis similar to Goodpasture syndrome but a. No associated renal disease b. No circulating anti-basement membrane antibody. Most cases occur in children, although the disease is reported in adults as well, who have a better prognosis With steroid and immunosuppressive therapy, survival has markedly improved from the historical 2.5 years; thus, an immune-mediated etiology is postulated

Diffuse alveolar hemorrhage syndrome perl sstain( an iron stain)

Lung cancer

Lung carcinoma

Lung cancer Lung tumors can be primary or secondary ( metastasis) Primary lung cancer is a relatively common disease. 95% of primary lung tumors are carcinomas, the remaining include other tumors like: carcinoid, lymphomas, mesenchymal tumors like fibrosarcoma and leiomyosarcoma. lung Carcinoma: Is the single most important cause of cancer-related deaths in industrialized countries accounts for about one third of cancer deaths in men, and has become the leading cause of cancer deaths in women

epidemiology -The peak incidence of lung cancer is in persons in their 50s and 60s. -The prognosis with lung cancer is poor: 1.The 5-year survival rate for all stages of lung cancer combined is about 16%, 2. Disease localized to the lung, the 5-year survival rate is 45%

Smoking and lung cancer - There is strong evidence that cigarette smoking and, to a much lesser extent, other environmental insults are responsible for the genetic changes in lung cancers. - About 90% of lung cancers occur in active smokers or those who stopped recently. - The increased risk becomes 60 times greater among habitual heavy smokers (two packs a day for 20 years) than among nonsmokers

- Since only 11% of heavy smokers develop lung cancer, however, other predisposing factors must play a role. - The mutagenic effect of carcinogens is conditioned by (genetic) factors. - Many chemicals (procarcinogens) require metabolic activation via the P- 450 monooxygenase enzyme system for conversion into ultimate carcinogens - Persons with specific genetic polymorphisms involving the P-450 genes have an increased capacity to metabolize procarcinogens derived from cigarette smoke, and thus have the greatest risk for development of lung cancer - For reasons not clear, women have a higher susceptibility to carcinogens in tobacco than men.

- Although cessation of smoking decreases the risk of developing lung cancer over time, it may never return to baseline levels - Passive smoking increases the risk of developing lung cancer to approximately twice that of nonsmoker - The smoking of pipes and cigars also increases the risk, but only modestly

PATHOGENESIS - Smoking-related carcinomas of the lung arise by a stepwise accumulation of a multitude of genetic abnormalities that result in transformation of benign progenitor cells in the lung into neoplastic cells.

- Among the major histologic subtypes of lung cancer, squamous and small-cell carcinomas show the strongest association with tobacco exposure. This is because smoking causes squamous metaplasia that progresses to dysplasia then carcinoma.

morphology The four major histologic types of carcinomas of the lung a. Adenocarcinoma b. Squamous cell carcinoma (SCC) c. Small cell carcinoma, d. Large cell carcinoma

Carcinomas of the lung were classified into two groups: a. Small cell lung cancer (SCLC) and.. These are neuroendocrine tumrs. b. Non-small cell lung cancer (NSCLC), including adenocarcinomas and squamous cell carcinomas The reason for this historical distinction was that virtually all SCLCs have metastasized by the time of diagnosis and are not curable by surgery and are treated by chemotherapy, with or without radiation therapy By contrast, NSCLCs were more likely to be respectable and usually responded poorly to chemotherapy however, now therapies are available that target specific mutated gene products present in the various subtypes of NSCLC, mainly in adenocarcinomas.

Mutations in lung cancer include 1. Inactivation of tumor suppressor genes located on the short arm of chromosome 3 2. TP53 mutations or activation of the KRAS are common in lung cancer. 3. In Adenocarcinomas a. Activating mutations of the epidermal growth factor receptor (EGFR) and these tumors are sensitive to agents that inhibit EGFR signaling, but the response often is short-lived. b. MET tyrosine kinase gene amplifications c. In 4% of adenocarcinomas are EML4-ALK tyrosine kinase fusion genes and

- The specific mutations in adenocarcinoma mentioned in the previous slide, while rare, are important because of their therapeutic implications, as they can be targeted with tyrosine kinase inhibitors. - The identification of genetic alterations producing overactive EGFR, ALK, and MET has opened up a new era of "personalized" lung cancer therapy

MORPHOLOGY 1. Squamous cell carcinomas : a. Are more common in men than in women b. Are closely correlated with a smoking history; c. They tend to arise centrally in major bronchi and eventually spread to local hilar nodes, d. Disseminate outside the thorax later than do other histologic types

Squamous cell carcinoma of lung

SCC.. Centrally located

SCC.. Keratin production

2. Adenocarcinomas: a. May occur as central lesions but usually are more peripherally located, many with a central scar. b. Are the most common type of lung cancer in women and nonsmokers c. In general, adenocarcinomas grow slowly and form smaller masses than do the other subtypes d. They tend to metastasize widely at an early stage

Adenocarcinoma: tumor forming glandular structures

Note: adenocarcinoma is usually peripherally located, squamous usually centrally located.

3. Small cell lung carcinomas (SCLCs) are: a. Centrally located with extension into the lung parenchyma b. Early involvement of the hilar and mediastinal nodes. c. Are composed of tumor cells with a round shape, scant cytoplasm, and finely granular chromatin with many mitotic figures.

- Necrosis is invariably present and may be extensive - Fragile cells that show fragmentation and "crush artifact". - Nuclear molding resulting from close apposition of tumor cells that have scant cytoplasm.

Small cell carcinoma of the lung

Crushing artefacts in small cell carcinoma

Pancoast tumor Apical lung neoplasms are called Pancoast tumors. These can be of any histological pattern. They can invade the brachial or cervical sympathetic plexus and cause severe pain in the distribution of the ulnar nerve.

Pancoast tumor

Pancoast tumor

Clinical Course of lung cancer - Are silent, cancers that in many cases have spread so as to be unresectable before they produce symptoms. - In some instances, chronic cough call attention to still localized, resectable disease. - By the time hoarseness, chest pain, superior vena cava syndrome, pleural effusion, makes its appearance, the prognosis is grim

- Too often, the tumor presents with symptoms resulting from metastatic spread to the brain (mental or neurologic changes), liver (hepatomegaly), or bones (pain). - Although the adrenals may be nearly obliterated by metastatic disease, adrenal insufficiency (Addison disease) is uncommon,

- About 3% to 10% of all patients with lung cancer develop clinically overt paraneoplastic syndromes. 1. Hypercalcemia: caused by secretion of a parathyroid hormone-related peptide by squamous cell carcinoma 2. Cushing syndrome (production of Adrenocorticotropic hormone);by small cell carcinoma 3. Syndrome of inappropriate secretion of antidiuretic hormone; by small cell carcinoma 4. neuromuscular syndromes, including a myasthenic syndrome, peripheral neuropathy, and polymyositis 5) clubbing of the fingers and hypertrophic pulmonary osteoarthropathy by any type of carcinoma

Carcinoid tumors These are malignant tumors composed of cells of neuroendocrine origin. They might secrete hormones.. Rarely They are resectable and curable. Please note that small cell carcinoma is also neuroendocrine in origin, but small cell has a very bad prognosis whereas carcinoid tumors have a much better prognosis.